Ledger.Open graph →
SEC Form D · filed June 16, 2016

NUVIANT MEDICAL INC

Offering
$825K
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David B. Kaysen · DALLAS, TXDirectorRonald Conquest · SCOTTSDALE, AZDirectorBrian B. Blischak · DALLAS, TXExec · DirectorChristopher R. Miller · DALLAS, TXExecAlexander Ruckdaeschel · New York, NYDirectorWilliam Rosellini · ALEXANDRIA, VAExec · DirectorDavid B. Kaysen · DALLAS, TXDirectorChristopher R. Miller · DALLAS, TXExecAlexander Ruckdaeschel · ROCHESTER, NYDirectorRonald Conquest · PHOENIX, AZDirectorBrian B. Blischak · DALLAS, TXExec · DirectorWilliam Rosellini · Los Angeles, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗